Pfizer assesses report on ‘possible serious allergic reaction’ to Covid-19 vaccine after Alaska health worker hospitalized – RT USA News

A health worker in Alaska has reportedly been hospitalized with a severe allergic reaction after taking Pfizer’s Covid-19 vaccine. They had no reported history of drug allergies, unlike others who have had such reactions.

The affected person remains in hospital on Wednesday after undergoing a vigorous reaction on Tuesday, three sources who saw official reports on the victim’s health told the New York Times. The health worker’s workplace or place of residence have not been disclosed, nor have more details about their health status been released, and it is not clear whether they had other non-medical allergies, one of the sources explained.

Pfizer is “Working with local health authorities” to get the details of the report on a “Possible serious allergic reaction,” the company told RT in a statement on Wednesday, promising “Closely monitor all reports indicating serious allergic reactions after vaccination” and Update the label language if necessary.

They added that too “No safety signs of concern have been identified in our clinical studies, including no sign of serious allergic reactions associated with the vaccine.”

Also at
WHO vaccination schedule with ‘very high’ risk of failure, leaving poor countries without Covid-19 shots until 2024 – report

The response was reportedly similar to the anaphylactic shock of multiple health professionals in the UK, where the Pfizer-BioNTech shot was approved earlier this month. One of the affected British women had a history of egg allergies, although the manufacturer insisted that there are no ingredients in the formula associated with eggs, and the other is said to be allergic to certain drugs. The UK also reported one “Possible allergic reaction” with a third recipient, although the incident was not described in detail.

UK health authorities have warned people with a history of this “Anaphylaxis to a Vaccine, Drug, or Food” away from getting the Covid-19 injection, and suggested that facilities set up to administer the vaccine be equipped with “Resuscitation Equipment” – guidance echoed in Pfizer’s own prescribing information.

Although the company did not report any allergic reactions in clinical trial participants, individuals with medical allergies, and anyone who ever had one “Serious side effect associated with a vaccine” were specifically excluded from the studies, and physicians were advised to watch for such reactions so that the allergic reaction could be eliminated from the studies.

Also at
Leaders in Britain and the US are pushing vaccines, but minorities are not lining up for the shot

The Food and Drug Administration issued an emergency use permit on Friday for the Pfizer-BioNTech vaccine, making the US the sixth country to approve the formula. The first 2.9 million doses were shipped to application sites on Sunday. Monday, the first two American health workers saw their injection in New York City.

The authorization is for adults aged 16 and over, and providers are advised not to give the vaccine to anyone “Known History of a Serious Allergic Reaction” to “Any part of the vaccine.” Primary health workers and nursing home residents will be first in line to receive the images.

The UK approved the vaccine earlier this month, the first country to give a green light to the use of an mRNA-based inoculation, and aims to have 800,000 residents vaccinated by the end of the year. Authorities complained that low-income and minority populations are less likely to express confidence in the vaccine compared to those with higher incomes, but blamed targeted anti-vaccine. “disinformation” for the statistics.

Also at
EU drug regulator brings forward a meeting on Pfizer’s Covid vaccine under pressure for approval before Christmas

While the British Medicines and Healthcare Products Regulatory Agency has insisted that it be a “Robust and Proactive Safety Monitoring Strategy for Covid-19 Vaccines” on the way, the agency’s contract with an artificial intelligence company “Coping with the expected high number of side effects from the Covid-19 vaccine” has not instilled confidence in skeptics.

Other countries, including Canada, Mexico, Singapore and Bahrain, have also given the green light to Pfizer’s shot. The US is expected to consider the Moderna jab. Another mRNA-based vaccine, it is produced by a company that has not yet successfully marketed a drug.

Do you like this story? Share it with a friend!